Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache

Research output: Contribution to journalReviewResearchpeer-review

  1. Post-Traumatic Stress Disorder After Traumatic Brain Injury-A Systematic Review and Meta-Analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment

    Research output: Contribution to journalReviewResearchpeer-review

  3. Postictal inhibition of the somatosensory cortex

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. CGRP in rat mesenteric artery and vein - receptor expression, CGRP presence and potential roles

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cellular distribution of PACAP-38 and PACAP receptors in the rat brain: Relation to migraine activated regions

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

Migraine is a common, severe disease, affecting the brain and blood vessels, causing much pain, time missed from work and family, and severe disability. It affects approximately 12% of most Western populations studied and affects women three times more than men. Cluster headache is a much less common dysfunction of the hypothalamus, involving the sphenopalatine ganglion and other areas; it causes more frequent, shorter, and even more intense pain than migraine. The pain usually comes in cycles and is associated with ipsilateral autonomic features and associated with irritability and inability to stay still. It affects less than 0.1% of the population and is slightly more prevalent in men than women. Although we have some acute care and preventive medications for both types of headache, no treatment is optimal for each patient and some will not respond well or have significant adverse events to existing therapies.

Original languageEnglish
JournalNeurological Sciences
Volume40
Issue numberSuppl 1
Pages (from-to)75-80
Number of pages6
ISSN1590-1874
DOIs
Publication statusPublished - May 2019
Externally publishedYes

    Research areas

  • CGRP, Cluster headache therapy, Headache devices, Migraine therapy, Monoclonal antibodies to calcitonin gene–related peptide or its receptor, Pathophysiology of migraine

ID: 57158493